|
(PQ1) GUCY2C hormone loss translates APC-Beta-catenin mutations into epithelial transformation
|
5R01CA206026-02
|
$356,850
|
WALDMAN, SCOTT
|
THOMAS JEFFERSON UNIVERSITY
|
|
(PQ1) Progenitor cell malfunction, mutations and changes in microenvironment: A dynamic risk spectrum for cancer evolution
|
1R01CA219893-01
|
$442,614
|
GHOSH, MOUMITA
|
NATIONAL JEWISH HEALTH
|
|
(PQ1) Progression of the airway field of injury to Kras mutant lung cancer
|
5R01CA205608-02
|
$346,909
|
SCHEET, PAUL
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
(PQ3) Identifying Novel Pharmacologic Risk factors for Common Non-AIDS Defining Cancers in Individuals with Well-controlled HIV Infection
|
5R01CA206476-02
|
$772,521
|
CHIAO, ELIZABETH
|
BAYLOR COLLEGE OF MEDICINE
|
|
(PQA1)The Molecular Mechanisms Underlying Effects of Aspirin on Colorectal Cancer
|
5R01CA184820-04
|
$386,650
|
DUBOIS, RAYMOND
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
(PQA4) Molecularly Targeted Chemoprevention for Preneoplastic Squamous (5R01 CA194617-02)
|
5R01CA194617-04
|
$412,607
|
TSAI, KENNETH
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
(PQC1) Accelerated biological aging and colon polyp to cancer progression
|
5R01CA194663-03
|
$401,482
|
GRADY, WILLIAM
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
0021.0001 CG 425 METAVIVOR
|
261200800001E
|
$319,219,481
|
UNKNOWN, UNKNOWN
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
15-Hydroxyprostaglandin Dehydrogenase, NSAIDs, Vitamin D, and Coloretcal Neoplasi
|
5U01CA181770-04
|
$507,599
|
LI, LI
|
CASE WESTERN RESERVE UNIVERSITY
|
|
15-LOX-1 Regulation of Resolving Generation to Modulate Colon Cancer
|
5R01CA195686-02
|
$366,000
|
SHUREIQI, IMAD
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
15-PGDH in Cholangiocarcinogenesis
|
5R01CA102325-11
|
$344,269
|
WU, TONG
|
TULANE UNIVERSITY OF LOUISIANA
|
|
402 -- CHEMOPREVENTION OF COLORECTAL CANCER . CONTRACTOR: UNIVERSITY OF OKLAHOMA, HEALTH SCIENCES CENTER, DUNS: 878648294. CONTRACT NO: HHSN261500038I, TASK ORDER HHSN26100011. FROM 9/15/17 TO 9/14/
|
261201500038I
|
$1,236,052
|
UNKNOWN, UNKNOWN
|
UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR
|
|
402 -- TARGETING THE MTOR PATHWAY FOR THE PREVENTION OF BREAST CANCER . CONTRACTOR: MD ANDERSON CANCER CENTER, DUNS: 800772139. CONTRACT NO: HHSN26120150008I, TASK ORDER HHSN26100006. FROM 9/15/17 T
|
261201500018I
|
$1,964,187
|
UNKNOWN, UNKNOWN
|
UT MD ANDERSON CANCER CTR
|
|
A Narrowed Window for Targeting Metabolic Flexibility in Breast Cancer Prevention
|
5R01CA164166-05
|
$322,663
|
MACLEAN, PAUL
|
UNIVERSITY OF COLORADO DENVER
|
|
A PHASE I DOSE ESCALATION STUDY OF TOPICAL BEXAROTENE IN WOMEN AT HIGH RISK FOR BREAST CANCER
|
261201200034I
|
$2,037,388
|
UNKNOWN, UNKNOWN
|
UT MD ANDERSON CANCER CTR
|
|
A PILOT STUDY OF MUC1 VACCINE IN CURRENT AND FORMER SMOKERS AT HIGH RISK FOR LUNG CANCER. (MAY2016-08-01)
|
261201200042I
|
$1,711,912
|
UNKNOWN, UNKNOWN
|
MAYO CLINIC ROCHESTER
|
|
A Prospective, Randomized Study to Compare Effects of Ulipristal Acetate with a Combined Oral Contraceptive on Breast Epithelial Cell Proliferation.
|
5R01CA200795-02
|
$494,977
|
WESTHOFF, CAROLYN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
A3AR agonists to prevent chemotherapy-induced painful peripheral neuropathy
|
5R01CA169519-05
|
$311,250
|
SALVEMINI, DANIELA
|
SAINT LOUIS UNIVERSITY
|
|
Aging mammary stem cells and breast cancer prevention
|
5R01CA192564-03
|
$395,434
|
SUN, LUZHE
|
UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
|
|
ANTI-FUSOBACTERIUM NUCLEATUM VACCINE FOR COLORECTAL CANCER (OPTION TASK 1) HHSN2612015000391/HHSN26100004
|
261201500039I
|
$627,879
|
UNKNOWN, UNKNOWN
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
Anticarcinogenic Effect of ITCs Against Prostate Cancer
|
5R01CA101753-13
|
$346,500
|
SINGH, SHIVENDRA
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Apigenin restores TSP-1 expression in UVB-irradiated keratinocytes
|
7R01CA172669-05
|
$436,213
|
VOLPERT, OLGA
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Aspirin and Cancer Prevention in Lynch Syndrome: From Cell to Population Data
|
5U01CA187956-04
|
$496,015
|
GOEL, AJAY
|
BAYLOR RESEARCH INSTITUTE
|
|
Aspirin Metabolomics in Colorectal Cancer Chemoprevention
|
5R01CA188038-03
|
$441,330
|
BARRY, ELIZABETH
|
DARTMOUTH COLLEGE
|
|
Aspirin-PC for Chemoprevention of Colorectal Cancer
|
2R42CA171408-02A1
|
$961,499
|
LICHTENBERGER, LENARD
|
PLX OPCO, INC.
|
|
Assessment of Breast Cancer Risk with High Spectral and Spatial Resolution MRI
|
5R01CA167785-05
|
$488,977
|
KARCZMAR, GREGORY
|
UNIVERSITY OF CHICAGO
|
|
ATBC Study
|
ZIA CP010195-03031
|
$1,161,432
|
N/A
|
DCEG (NCI)
|
|
Barrett's Esophagus: Predictors of Progression
|
5P01CA091955-14
|
$1,731,544
|
REID, BRIAN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S1
|
$118,333
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S2
|
$118,875
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S3
|
$122,250
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S4
|
$250,002
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-11
|
$3,253,119
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Bid-mediated killing of oncogenic stem cells in chemoprevention
|
5R01CA172136-05
|
$319,550
|
ZHANG, LIN
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Biobehavioral Cancer Control and Prevention Training Grant
|
5T32CA092408-17
|
$347,645
|
PATRICK, DONALD
|
UNIVERSITY OF WASHINGTON
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIA BC 010030
|
$755,842
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
Bitter Melon Component and Colon Cancer Prevention
|
5R01CA190291-04
|
$544,710
|
ANANT, SHRIKANT
|
UNIVERSITY OF KANSAS MEDICAL CENTER
|
|
Breast Cancer Prevention by Ayurvedic Medicine Constituents
|
5R01CA142604-08
|
$346,500
|
SINGH, SHIVENDRA
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Breast imaging studies in women at high genetic risk of breast cancer
|
ZIA CP010145-07040
|
$23,893
|
Loud, Jennifer
|
DCEG (NCI)
|
|
Calcium and Colorectal Cancer: Gene-Environment Interactions and Molecular Pathways
|
5K07CA188126-03
|
$144,000
|
ZHANG, XUEHONG
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Cancer and Stem Cell Dynamics in the Intestine
|
4R00CA181679-03
|
$248,992
|
FISCHER, JARED
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
Cancer Center Support (CORE) Grant
|
3P30CA016672-42S1
|
$123,768
|
DMITROVSKY, ETHAN
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Cancer Center Support (CORE) Grant
|
3P30CA016672-42S2
|
$75,000
|
DMITROVSKY, ETHAN
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Cancer Center Support (CORE) Grant
|
3P30CA016672-42S3
|
$120,000
|
DMITROVSKY, ETHAN
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Cancer Center Support (CORE) Grant
|
3P30CA016672-42S4
|
$50,000
|
DMITROVSKY, ETHAN
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Cancer Center Support (CORE) Grant
|
5P30CA016672-42
|
$10,405,362
|
DMITROVSKY, ETHAN
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Cancer Center Support Grant
|
3P30CA033572-34S1
|
$73,297
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cancer Center Support Grant
|
3P30CA033572-34S2
|
$124,999
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cancer Center Support Grant
|
5P30CA033572-34
|
$2,446,682
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cancer Center Support Grant
|
3P30CA013696-43S1
|
$120,000
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|